AMLo Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- AMLo Biosciences's estimated annual revenue is currently $2M per year.
- AMLo Biosciences's estimated revenue per employee is $77,500
- AMLo Biosciences's total funding is $8M.
Employee Data
- AMLo Biosciences has 26 Employees.
- AMLo Biosciences grew their employee count by -4% last year.
AMLo Biosciences's People
| Name | Title | Email/Phone |
|---|
AMLo Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2M | 26 | -4% | $8.42M | N/A |
What Is AMLo Biosciences?
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression. Those patients who are genuinely at low-risk of disease spread can be provided reassurance and better-informed follow-up care, while those identified at risk of metastasis are enabled to receive timely treatment. The test under development – AMBLor® – will be simple to use and fits seamlessly into current diagnostic practice. AMLo Biosciences has been founded by a team with an internationally acclaimed research track record in the melanoma field, through identification of translational biomarkers, drug discovery & development and the building of biotech companies.
keywords:N/A
$8M
Total Funding
26
Number of Employees
$2M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Newcastle upon Tyne
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10.1M | 26 | 0% | N/A |
#2 | $3.2M | 29 | -17% | $5M |
#3 | $5.2M | 37 | 0% | N/A |
#4 | $5.5M | 39 | -5% | N/A |
#5 | $6.7M | 43 | -12% | $6M |